Laurus Labs has seen its consensus analyst price target edge up slightly from ₹815.86 to ₹821.93. This signals renewed confidence among market watchers. This shift comes as experts weigh in on the ...

Laurus Labs share price jumps near ₹1,103, close to a record high. Strong Q3 results, rising CDMO growth and bullish analyst ...

Laurus Labs latest update leaves the fair value estimate at roughly ₹821.93 per share with a steady discount rate of 12.76%, underscoring that the market narrative is shifting more on expectations ...

SUNNYVALE, Calif., May 30, 2024 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of ...

Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1280 in its research report dated February 25, 2026.

In comparison to its peers, Laurus Labs has delivered stronger execution, reporting a 30% growth from the previous year and ...

Laurus Labs, a pharma company, is showing signs of recovery after a recent dip. Experts suggest short-term traders with a ...

Laurus Labs share price rose over 2% during Monday's trading session to touch an 52-week high of ₹720.90 apiece on the BSE, marking the stock's third consecutive day of gains in a bullish trend. So ...

Laurus Labs Limited was originally incorporated as Laurus Labs Private Limited on September 19, 2005 at Hyderabad, Andhra Pradesh, India as a private limited company. The company was subsequently ...

When Dr Satyanarayana Chava started Laurus Labs in 2007, he invested nearly Rs 60 crore of his own money into it. His confidence in its success was neither bravado nor bluster, but defined by his ...

2 Annual General Meeting / Dividend- Rs 1.50 Per Share 28-Jun-18- 2 Annual General Meeting/Dividend - Rs 1.50/- Per Share 06-Jul-17- Catch latest stock market updates here. For all other news related ...

The strategic alliance includes an initial seven high-value advanced intermediates and active pharmaceutical ingredients, including Willow's corticosteroid programs The agreement with Laurus is the ...